ID   ARK72_HUMAN             Reviewed;         359 AA.
AC   O43488; O75749; Q5TG63;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   14-NOV-2003, sequence version 3.
DT   15-MAR-2017, entry version 166.
DE   RecName: Full=Aflatoxin B1 aldehyde reductase member 2;
DE            EC=1.1.1.n11;
DE   AltName: Full=AFB1 aldehyde reductase 1;
DE            Short=AFB1-AR 1;
DE   AltName: Full=Aldoketoreductase 7;
DE   AltName: Full=Succinic semialdehyde reductase;
DE            Short=SSA reductase;
GN   Name=AKR7A2; Synonyms=AFAR, AFAR1, AKR7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2-359.
RC   TISSUE=Pancreas, Skin, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 5-359, PARTIAL PROTEIN SEQUENCE,
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND
RP   VARIANT THR-142.
RC   TISSUE=Liver;
RX   PubMed=9576847; DOI=10.1042/bj3320021;
RA   Ireland L.S., Harrison D.J., Neal G.E., Hayes J.D.;
RT   "Molecular cloning, expression and catalytic activity of a human AKR7
RT   member of the aldo-keto reductase superfamily: evidence that the major
RT   2-carboxybenzaldehyde reductase from human liver is a homologue of rat
RT   aflatoxin B1-aldehyde reductase.";
RL   Biochem. J. 332:21-34(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 7-359.
RC   TISSUE=Brain;
RX   PubMed=9823300;
RA   Praml C., Savelyeva L., Perri P., Schwab M.;
RT   "Cloning of the human aflatoxin B1-aldehyde reductase gene at 1p35-
RT   1p36.1 in a region frequently altered in human tumor cells.";
RL   Cancer Res. 58:5014-5018(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 30-359.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   PROTEIN SEQUENCE OF 222-236; 251-261 AND 279-297, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Vishwanath V.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [7]
RP   CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=10510318; DOI=10.1042/bj3430487;
RA   O'Connor T., Ireland L.S., Harrison D.J., Hayes J.D.;
RT   "Major differences exist in the function and tissue-specific
RT   expression of human aflatoxin B1 aldehyde reductase and the principal
RT   human aldo-keto reductase AKR1 family members.";
RL   Biochem. J. 343:487-504(1999).
RN   [8]
RP   GENE STRUCTURE.
RX   PubMed=12071861; DOI=10.1042/BJ20020342;
RA   Kelly V.P., Sherratt P.J., Crouch D.H., Hayes J.D.;
RT   "Novel homodimeric and heterodimeric rat gamma-hydroxybutyrate
RT   synthases that associate with the Golgi apparatus define a distinct
RT   subclass of aldo-keto reductase 7 family proteins.";
RL   Biochem. J. 366:847-861(2002).
RN   [9]
RP   FUNCTION.
RX   PubMed=17591773; DOI=10.1074/jbc.M702465200;
RA   Lyon R.C., Johnston S.M., Watson D.G., McGarvie G., Ellis E.M.;
RT   "Synthesis and catabolism of gamma-hydroxybutyrate in SH-SY5Y human
RT   neuroblastoma cells: role of the aldo-keto reductase AKR7A2.";
RL   J. Biol. Chem. 282:25986-25992(2007).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-255, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-255, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) IN COMPLEX WITH NADP.
RG   Structural genomics consortium (SGC);
RT   "Structure of the aflatoxin aldehyde reductase in complex with
RT   NADPH.";
RL   Submitted (FEB-2009) to the PDB data bank.
RN   [15]
RP   VARIANTS THR-142 AND HIS-157.
RX   PubMed=18752886; DOI=10.1016/j.canlet.2008.07.013;
RA   Praml C., Schulz W., Claas A., Mollenhauer J., Poustka A.,
RA   Ackermann R., Schwab M., Henrich K.-O.;
RT   "Genetic variation of aflatoxin B1 aldehyde reductase genes (AFAR) in
RT   human tumour cells.";
RL   Cancer Lett. 272:160-166(2008).
CC   -!- FUNCTION: Catalyzes the NADPH-dependent reduction of succinic
CC       semialdehyde to gamma-hydroxybutyrate. May have an important role
CC       in producing the neuromodulator gamma-hydroxybutyrate (GHB). Has
CC       broad substrate specificity. Has NADPH-dependent aldehyde
CC       reductase activity towards 2-carboxybenzaldehyde, 2-
CC       nitrobenzaldehyde and pyridine-2-aldehyde (in vitro). Can reduce
CC       1,2-naphthoquinone and 9,10-phenanthrenequinone (in vitro). Can
CC       reduce the dialdehyde protein-binding form of aflatoxin B1 (AFB1)
CC       to the non-binding AFB1 dialcohol. May be involved in protection
CC       of liver against the toxic and carcinogenic effects of AFB1, a
CC       potent hepatocarcinogen. {ECO:0000269|PubMed:17591773,
CC       ECO:0000269|PubMed:9576847}.
CC   -!- CATALYTIC ACTIVITY: 4-hydroxybutanoate + NADP(+) = succinate
CC       semialdehyde + NADPH. {ECO:0000269|PubMed:10510318}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=20 uM for succinic semialdehyde
CC         {ECO:0000269|PubMed:10510318};
CC         KM=17 uM for 2-carboxybenzaldehyde
CC         {ECO:0000269|PubMed:10510318};
CC         KM=8 uM for 9,10-phenanthrenequinone
CC         {ECO:0000269|PubMed:10510318};
CC         KM=102 uM for 1,2-naphthoquinone {ECO:0000269|PubMed:10510318};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:9576847,
CC       ECO:0000269|Ref.14}.
CC   -!- INTERACTION:
CC       O95154:AKR7A3; NbExp=3; IntAct=EBI-748855, EBI-748869;
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus {ECO:0000250}. Cytoplasm
CC       {ECO:0000269|PubMed:9576847}.
CC   -!- TISSUE SPECIFICITY: Detected in brain, liver, small intestine and
CC       testis, and at lower levels in heart, prostate, skeletal muscle
CC       and spleen. Detected in kidney proximal and distal tubules,
CC       endothelial cells lining the Bowman's capsules and some cysts.
CC       Detected at low levels in lung and pancreas (at protein level).
CC       Widely expressed. {ECO:0000269|PubMed:10510318,
CC       ECO:0000269|PubMed:9576847}.
CC   -!- SIMILARITY: Belongs to the aldo/keto reductase family. Aldo/keto
CC       reductase 2 subfamily. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-30 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC52104.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAH04111.3; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAH10852.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAH11586.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAH12171.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAH13996.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAP36011.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAA76347.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAB72321.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL035413; CAB72321.1; ALT_INIT; Genomic_DNA.
DR   EMBL; BC004111; AAH04111.3; ALT_INIT; mRNA.
DR   EMBL; BC007352; AAH07352.2; -; mRNA.
DR   EMBL; BC010852; AAH10852.1; ALT_INIT; mRNA.
DR   EMBL; BC011586; AAH11586.1; ALT_INIT; mRNA.
DR   EMBL; BC012171; AAH12171.1; ALT_INIT; mRNA.
DR   EMBL; BC013996; AAH13996.1; ALT_INIT; mRNA.
DR   EMBL; AF026947; AAC52104.1; ALT_INIT; mRNA.
DR   EMBL; Y16675; CAA76347.1; ALT_INIT; mRNA.
DR   EMBL; BT007347; AAP36011.1; ALT_INIT; mRNA.
DR   EMBL; BK000395; DAA00088.1; -; mRNA.
DR   CCDS; CCDS194.1; -.
DR   RefSeq; NP_003680.2; NM_003689.3.
DR   UniGene; Hs.571886; -.
DR   PDB; 2BP1; X-ray; 2.40 A; A/B/C/D=30-359.
DR   PDBsum; 2BP1; -.
DR   ProteinModelPortal; O43488; -.
DR   SMR; O43488; -.
DR   BioGrid; 114142; 34.
DR   IntAct; O43488; 30.
DR   MINT; MINT-5002225; -.
DR   STRING; 9606.ENSP00000235835; -.
DR   iPTMnet; O43488; -.
DR   PhosphoSitePlus; O43488; -.
DR   SwissPalm; O43488; -.
DR   BioMuta; AKR7A2; -.
DR   REPRODUCTION-2DPAGE; IPI00305978; -.
DR   REPRODUCTION-2DPAGE; O43488; -.
DR   UCD-2DPAGE; O43488; -.
DR   EPD; O43488; -.
DR   PaxDb; O43488; -.
DR   PeptideAtlas; O43488; -.
DR   PRIDE; O43488; -.
DR   DNASU; 8574; -.
DR   Ensembl; ENST00000235835; ENSP00000235835; ENSG00000053371.
DR   GeneID; 8574; -.
DR   KEGG; hsa:8574; -.
DR   CTD; 8574; -.
DR   DisGeNET; 8574; -.
DR   GeneCards; AKR7A2; -.
DR   H-InvDB; HIX0000198; -.
DR   HGNC; HGNC:389; AKR7A2.
DR   HPA; CAB032587; -.
DR   HPA; CAB032841; -.
DR   HPA; HPA064638; -.
DR   MIM; 603418; gene.
DR   neXtProt; NX_O43488; -.
DR   OpenTargets; ENSG00000053371; -.
DR   PharmGKB; PA24682; -.
DR   eggNOG; ENOG410IDYD; Eukaryota.
DR   eggNOG; COG0667; LUCA.
DR   GeneTree; ENSGT00550000074567; -.
DR   HOGENOM; HOG000250286; -.
DR   HOVERGEN; HBG050576; -.
DR   InParanoid; O43488; -.
DR   KO; K15303; -.
DR   OMA; CTVKIAT; -.
DR   OrthoDB; EOG091G0BTK; -.
DR   PhylomeDB; O43488; -.
DR   TreeFam; TF329173; -.
DR   Reactome; R-HSA-5423646; Aflatoxin activation and detoxification.
DR   SABIO-RK; O43488; -.
DR   EvolutionaryTrace; O43488; -.
DR   GeneWiki; AKR7A2; -.
DR   GenomeRNAi; 8574; -.
DR   PMAP-CutDB; O43488; -.
DR   PRO; PR:O43488; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000053371; -.
DR   CleanEx; HS_AKR7A2; -.
DR   ExpressionAtlas; O43488; baseline and differential.
DR   Genevisible; O43488; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0004032; F:alditol:NADP+ 1-oxidoreductase activity; TAS:ProtInc.
DR   GO; GO:0004033; F:aldo-keto reductase (NADP) activity; TAS:Reactome.
DR   GO; GO:0009055; F:electron carrier activity; TAS:UniProtKB.
DR   GO; GO:0019119; F:phenanthrene-9,10-epoxide hydrolase activity; IDA:UniProtKB.
DR   GO; GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc.
DR   GO; GO:0006081; P:cellular aldehyde metabolic process; TAS:ProtInc.
DR   GO; GO:0044597; P:daunorubicin metabolic process; IMP:UniProtKB.
DR   GO; GO:0044598; P:doxorubicin metabolic process; IMP:UniProtKB.
DR   GO; GO:0006805; P:xenobiotic metabolic process; TAS:Reactome.
DR   CDD; cd06660; Aldo_ket_red; 1.
DR   Gene3D; 3.20.20.100; -; 1.
DR   InterPro; IPR023210; NADP_OxRdtase_dom.
DR   Pfam; PF00248; Aldo_ket_red; 1.
DR   SUPFAM; SSF51430; SSF51430; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Golgi apparatus; NADP; Oxidoreductase;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1    359       Aflatoxin B1 aldehyde reductase member 2.
FT                                /FTId=PRO_0000070375.
FT   NP_BIND     171    172       NADP. {ECO:0000269|Ref.14}.
FT   NP_BIND     226    236       NADP. {ECO:0000269|Ref.14}.
FT   NP_BIND     318    326       NADP. {ECO:0000269|Ref.14}.
FT   ACT_SITE     77     77       Proton donor. {ECO:0000250}.
FT   BINDING      72     72       NADP. {ECO:0000269|Ref.14}.
FT   BINDING     141    141       Substrate. {ECO:0000250}.
FT   BINDING     197    197       NADP. {ECO:0000269|Ref.14}.
FT   BINDING     250    250       NADP. {ECO:0000269|Ref.14}.
FT   BINDING     260    260       Substrate. {ECO:0000250}.
FT   BINDING     263    263       Substrate. {ECO:0000250}.
FT   BINDING     359    359       Substrate. {ECO:0000250}.
FT   SITE        105    105       Lowers pKa of active site Tyr.
FT                                {ECO:0000250}.
FT   MOD_RES      10     10       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P38918}.
FT   MOD_RES     113    113       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O95154}.
FT   MOD_RES     128    128       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8CG76}.
FT   MOD_RES     236    236       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8CG76}.
FT   MOD_RES     255    255       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   VARIANT     135    135       V -> M (in dbSNP:rs6670759).
FT                                /FTId=VAR_048209.
FT   VARIANT     142    142       A -> T (in dbSNP:rs1043657).
FT                                {ECO:0000269|PubMed:18752886,
FT                                ECO:0000269|PubMed:9576847}.
FT                                /FTId=VAR_017413.
FT   VARIANT     157    157       Q -> H (in dbSNP:rs859208).
FT                                {ECO:0000269|PubMed:18752886}.
FT                                /FTId=VAR_017414.
FT   VARIANT     180    180       E -> K (in dbSNP:rs859210).
FT                                /FTId=VAR_060222.
FT   VARIANT     198    198       G -> S (in dbSNP:rs2231200).
FT                                /FTId=VAR_048210.
FT   VARIANT     214    214       C -> Y (in dbSNP:rs2235794).
FT                                /FTId=VAR_017415.
FT   VARIANT     255    255       S -> N (in dbSNP:rs2231203).
FT                                /FTId=VAR_048211.
FT   STRAND       39     43       {ECO:0000244|PDB:2BP1}.
FT   TURN         48     50       {ECO:0000244|PDB:2BP1}.
FT   HELIX        53     65       {ECO:0000244|PDB:2BP1}.
FT   STRAND       70     72       {ECO:0000244|PDB:2BP1}.
FT   HELIX        77     80       {ECO:0000244|PDB:2BP1}.
FT   HELIX        81     87       {ECO:0000244|PDB:2BP1}.
FT   STRAND      101    106       {ECO:0000244|PDB:2BP1}.
FT   HELIX       116    130       {ECO:0000244|PDB:2BP1}.
FT   STRAND      135    140       {ECO:0000244|PDB:2BP1}.
FT   HELIX       149    161       {ECO:0000244|PDB:2BP1}.
FT   STRAND      164    172       {ECO:0000244|PDB:2BP1}.
FT   HELIX       175    188       {ECO:0000244|PDB:2BP1}.
FT   STRAND      193    199       {ECO:0000244|PDB:2BP1}.
FT   HELIX       206    208       {ECO:0000244|PDB:2BP1}.
FT   HELIX       211    218       {ECO:0000244|PDB:2BP1}.
FT   STRAND      221    225       {ECO:0000244|PDB:2BP1}.
FT   HELIX       229    234       {ECO:0000244|PDB:2BP1}.
FT   HELIX       239    242       {ECO:0000244|PDB:2BP1}.
FT   TURN        243    245       {ECO:0000244|PDB:2BP1}.
FT   STRAND      252    254       {ECO:0000244|PDB:2BP1}.
FT   HELIX       257    264       {ECO:0000244|PDB:2BP1}.
FT   HELIX       267    284       {ECO:0000244|PDB:2BP1}.
FT   HELIX       285    287       {ECO:0000244|PDB:2BP1}.
FT   HELIX       291    302       {ECO:0000244|PDB:2BP1}.
FT   HELIX       307    309       {ECO:0000244|PDB:2BP1}.
FT   STRAND      312    315       {ECO:0000244|PDB:2BP1}.
FT   HELIX       320    330       {ECO:0000244|PDB:2BP1}.
FT   HELIX       337    350       {ECO:0000244|PDB:2BP1}.
FT   HELIX       351    353       {ECO:0000244|PDB:2BP1}.
SQ   SEQUENCE   359 AA;  39589 MW;  2C9775FE4B977D2A CRC64;
     MLSAASRVVS RAAVHCALRS PPPEARALAM SRPPPPRVAS VLGTMEMGRR MDAPASAAAV
     RAFLERGHTE LDTAFMYSDG QSETILGGLG LGLGGGDCRV KIATKANPWD GKSLKPDSVR
     SQLETSLKRL QCPQVDLFYL HAPDHGTPVE ETLHACQRLH QEGKFVELGL SNYASWEVAE
     ICTLCKSNGW ILPTVYQGMY NATTRQVETE LFPCLRHFGL RFYAYNPLAG GLLTGKYKYE
     DKDGKQPVGR FFGNSWAETY RNRFWKEHHF EAIALVEKAL QAAYGASAPS VTSAALRWMY
     HHSQLQGAHG DAVILGMSSL EQLEQNLAAT EEGPLEPAVV DAFNQAWHLV AHECPNYFR
//
